Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus
New data visualizations from STAT explore the breadth of the pharmaceutical industry's campaign spending ahead of the 2020 election.
Read The StoryPrescription Politics
This series explores the pharmaceutical industry’s efforts to influence politicians. The first uses data visualizations to explore donations from 25 drug company and trade association PACs to more than two-thirds of the sitting members of Congress. Forthcoming work will explore the industry’s giving at the state level. For more of STAT’s coverage of the drug industry’s influence in Washington, sign up to our free newsletter, D.C. Diagnosis, or subscribe to STAT+.
How a billionaire couple greased the skids for Nancy Pelosi’s drug pricing bill
How pharma, under attack from all sides, keeps winning in Washington
The Democrats shepherding Pelosi’s drug pricing bill have taken plenty of campaign cash from pharma
